Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021–2024
We tested cross-neutralization against highly pathogenic avian influenza A(H5N1) virus in adults vaccinated with 2021-2023 seasonal quadrivalent influenza vaccine in the United Kingdom. Seasonal quadrivalent influenza vaccines are unlikely to protect vulnerable persons against severe H5N1 disease during widespread transmission. Enhanced measures are needed to protect vulnerable people from H5N1 virus infection.
Authors
- Vincenzo Libri (ORCID: https://orcid.org/0000-0003-1995-8895)
- Emma Wall (ORCID: https://orcid.org/0000-0003-2732-4497)
- Charles Swanton (ORCID: https://orcid.org/0000-0002-4299-3018)
- Bryan Williams (ORCID: https://orcid.org/0000-0002-8094-1841)
- Ruth Harvey (ORCID: https://orcid.org/0000-0002-1428-9621)
- Edward J Carr (ORCID: https://orcid.org/0000-0001-9343-4593)
- David Greenwood (ORCID: https://orcid.org/0009-0004-0360-1351)
- Lorin Adams (ORCID: https://orcid.org/0000-0001-8357-2327)
- Steve J. Gamblin (ORCID: https://orcid.org/0000-0001-5331-639X)
- Nicola S. Lewis (ORCID: https://orcid.org/0000-0001-9496-4756)
- Phoebe Stevenson-Leggett (ORCID: https://orcid.org/0000-0002-6509-3354)
- Mary Wu (ORCID: https://orcid.org/0000-0002-2074-6171)
- Abi Lofts
- Sonia Gandhi (ORCID: https://orcid.org/0000-0003-4395-2661)
Publication Details
- Journal
- Emerging infectious diseases
- Published
- 2025-05-28
- DOI
- https://doi.org/10.3201/eid3106.241796
- Citations
- 4
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.42